Myriad Genetics Inc. Newsletter
-
Zydus Signs Exclusive Pact with US-Based Myriad Genetics to Launch Cancer Diagnostic Tests in India
19 Dec 2025 12:06 GMT
… exclusive agreement with US-based Myriad Genetics to introduce a range of … , Zydus will market and promote Myriad Genetics’ diagnostic platforms, including the MyRisk … .
Brian Donnelly, Chief Commercial Officer, Myriad Genetics, said the partnership with Zydus …
-
Zydus Lifesciences Limited signs an exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India
19 Dec 2025 09:31 GMT
… ("Agreement") with Myriad Genetics, a leader in molecular diagnostic … oncology, this collaboration with Myriad Genetics will strengthen clinician education and … engage clinicians on three of Myriad Genetics' broadly validated diagnostic …
-
Zydus partners with Myriad Genetics to launch cancer-risk assessment diagnostic tests in India
19 Dec 2025 08:49 GMT
… oncology, this collaboration with Myriad Genetics will strengthen clinician education and … Donnelly, Chief Commercial Officer for Myriad Genetics. “Myriad tests aim to … engage clinicians on three of Myriad Genetics’ broadly validated diagnostic platforms, …
-
Zydus ties up with US-based Myriad Genetics to launch cancer-risk assessment diagnostic tests in India
19 Dec 2025 07:40 GMT
… exclusive agreement with US-based Myriad Genetics.
As part of this agreement …
-
Zydus Lifesciences signs exclusive agreement with Myriad Genetics to launch advanced cancer genomic tests in India
19 Dec 2025 04:46 GMT
… into a strategic agreement with Myriad Genetics, a global leader in molecular … market and promote three of Myriad Genetics’ diagnostic platforms in India: the …
-
Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium
09 Dec 2025 14:00 GMT
… Simmons, PhD, Biostatistician III, Myriad Genetics Enhancing breast cancer risk assessment … Simmons, PhD, Biostatistician III, Myriad Genetics Co-occurring pathogenic variants in … (30):3468-3493 About Myriad Genetics
Myriad Genetics is a leading molecular …
-
Myriad Genetics partners to use AI to measure breast cancer risk
26 Nov 2025 05:48 GMT
… /iStock via Getty Images Myriad Genetics (MYRD) is partnering with Clairity …
-
Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health
25 Nov 2025 21:15 GMT
… 2025 (GLOBE NEWSWIRE) -- Clairity, Myriad Genetics, Inc. (NASDAQ: MYGN), and MagView … directly from a routine mammogram
Myriad Genetics – a leader in molecular … #47;clairity-breast/. About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic …
-
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
11 Nov 2025 14:00 GMT
… . 11, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader … at investor.myriad.com. About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic … and well-being for all. Myriad Genetics develops and offers molecular tests …
-
Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs
10 Nov 2025 13:30 GMT
… 10, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a … Muzzey, PhD, Chief Scientific Officer, Myriad Genetics. “Medical societies recommend genes for … use in any way.
About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic …
About
© 1995-2025